Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash from Operations (2020 - 2025)

Bio Essence has reported Cash from Operations over the past 6 years, most recently at 1241052.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 1241052.0 for Q4 2025, up 182.69% from a year ago — trailing twelve months through Dec 2025 was 1569753.0 (up 145.34% YoY), and the annual figure for FY2025 was 1569753.0, up 145.34%.
  • Cash from Operations for Q4 2025 was 1241052.0 at Bio Essence, up from 186973.0 in the prior quarter.
  • Over the last five years, Cash from Operations for BIOE hit a ceiling of 1241052.0 in Q4 2025 and a floor of 824074.0 in Q4 2023.
  • Median Cash from Operations over the past 5 years was 82114.0 (2022), compared with a mean of 40673.1.
  • Biggest five-year swings in Cash from Operations: plummeted 537.42% in 2023 and later soared 998.65% in 2025.
  • Bio Essence's Cash from Operations stood at 142565.0 in 2021, then grew by 9.32% to 129283.0 in 2022, then plummeted by 537.42% to 824074.0 in 2023, then soared by 153.27% to 439018.0 in 2024, then soared by 182.69% to 1241052.0 in 2025.
  • The last three reported values for Cash from Operations were 1241052.0 (Q4 2025), 186973.0 (Q3 2025), and 167797.0 (Q2 2025) per Business Quant data.